Trial Profile
A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 26 Feb 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 24 May 2012 Planned initiation date changed from 1 Dec 2011 to 1 May 2012 as reported by ClinicalTrials.gov.
- 01 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.